Moreover, it is generally accepted that mutations in the gene encoding BMPRII are responsible for patients with PAH and BMPRII expression is also decreased in PAH patients without BMPRII mutations [11], indicating that BMPRII signaling plays a crucial role in the development of PAH. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.